Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Melanoma

Clinical trial condition

Recurrent Melanoma

Explore clinical trials studying Recurrent Melanoma. Study availability and eligibility vary by location and protocol.

83 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Melanoma trial results

Completed

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

NCT01961115

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +25 more
Locations: Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Duke University Medical Center Durham, North Carolina, United States

Cleveland Clinic Foundation Cleveland, Ohio, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Completed

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00450255

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +22 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

NCT00387751

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma

NCT00019682

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Kaiser Permanente Medical Center Riverside, California, United States

University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States

View all 19 locations

View Trial Details

Completed

Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma

NCT00397982

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Completed

Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

NCT01898403

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Stanford University Hospitals and Clinics Stanford, California, United States

View Trial Details

Completed

Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma

NCT00871481

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma

NCT00060333

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic - Jacksonville Jacksonville, Florida, United States

Joliet Oncology-Hematology Associates, Limited - West Joliet, Illinois, United States

Mercy Capitol Hospital Des Moines, Iowa, United States

View all 39 locations

View Trial Details

Completed

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

NCT00003895

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +18 more
Locations: Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

NCT00553306

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details